Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Hawkins

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 24, 2025
Leveling up: Treating Uptake as Endogenous May Increase the Value of Screening ProgramsJose A Robles-Zurita, Neil Hawkins, Janet Bouttell
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 15, 2006
Probabilistic analysis and computationally expensive models: Necessary and required?Susan Griffin, Karl Claxton, Neil Hawkins, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 4, 2009
Cost-effectiveness of scheduled maintenance treatment with infliximab for pediatric Crohn's diseaseYogesh Suresh Punekar, Thomas Sunderland, Neil Hawkins, et al.
Journal of Market Access & Health Policy|January 27, 2025
Assessing the Value of Further Investment in R&D Using Mixed Methods: A Case Study of Biosensor-Integrated Arteriovenous GraftsSamuel Owusu Achiaw, Neil Hawkins, Olivia Wu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 9, 2020
Nonproportional Hazards in Network Meta-Analysis: Efficient Strategies for Model Building and AnalysisAnna Wiksten, Neil Hawkins, Hans-Peter Piepho, et al.
Current Medical Research and Opinion|May 11, 2013
The efficacy and tolerability of perampanel and other recently approved anti-epileptic drugs for the treatment of refractory partial onset seizure: a systematic review and Bayesian network meta-analysisNasreen Khan, Dhvani Shah, Vanita Tongbram, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 15, 2018
Value of External Data in the Extrapolation of Survival Data: A Study Using the NJR Data SetMark Pennington, Richard Grieve, Jan Van der Meulen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 1, 2009
No study left behind: a network meta-analysis in non-small-cell lung cancer demonstrating the importance of considering all relevant dataNeil Hawkins, David A Scott, Beth S Woods, et al.
Journal of Comparative Effectiveness Research|August 29, 2023
Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of careNeil Hawkins, Noemi Muszbek, Rachel Evans, et al.
European Journal of Gastroenterology & Hepatology|April 29, 2015
Comparative effectiveness of antiviral treatment for hepatitis B: a systematic review and Bayesian network meta-analysisLindsay Govan, Olivia Wu, Yiqiao Xin, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 24, 2025
Leveling up: Treating Uptake as Endogenous May Increase the Value of Screening ProgramsJose A Robles-Zurita, Neil Hawkins, Janet Bouttell
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 15, 2006
Probabilistic analysis and computationally expensive models: Necessary and required?Susan Griffin, Karl Claxton, Neil Hawkins, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 4, 2009
Cost-effectiveness of scheduled maintenance treatment with infliximab for pediatric Crohn's diseaseYogesh Suresh Punekar, Thomas Sunderland, Neil Hawkins, et al.
Journal of Market Access & Health Policy|January 27, 2025
Assessing the Value of Further Investment in R&D Using Mixed Methods: A Case Study of Biosensor-Integrated Arteriovenous GraftsSamuel Owusu Achiaw, Neil Hawkins, Olivia Wu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 9, 2020
Nonproportional Hazards in Network Meta-Analysis: Efficient Strategies for Model Building and AnalysisAnna Wiksten, Neil Hawkins, Hans-Peter Piepho, et al.
Current Medical Research and Opinion|May 11, 2013
The efficacy and tolerability of perampanel and other recently approved anti-epileptic drugs for the treatment of refractory partial onset seizure: a systematic review and Bayesian network meta-analysisNasreen Khan, Dhvani Shah, Vanita Tongbram, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 15, 2018
Value of External Data in the Extrapolation of Survival Data: A Study Using the NJR Data SetMark Pennington, Richard Grieve, Jan Van der Meulen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 1, 2009
No study left behind: a network meta-analysis in non-small-cell lung cancer demonstrating the importance of considering all relevant dataNeil Hawkins, David A Scott, Beth S Woods, et al.
Journal of Comparative Effectiveness Research|August 29, 2023
Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of careNeil Hawkins, Noemi Muszbek, Rachel Evans, et al.
European Journal of Gastroenterology & Hepatology|April 29, 2015
Comparative effectiveness of antiviral treatment for hepatitis B: a systematic review and Bayesian network meta-analysisLindsay Govan, Olivia Wu, Yiqiao Xin, et al.
Pageof 11